Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004580 · ClinicalTrials.gov registry record · Phase 1
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00004580 is a Phase 1 study that has completed, run by Abbott.
The verdict
NCT00004580, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
The purpose of this study is to see if it is safe and effective to give ABT-378/ritonavir combination plus nevirapine plus two nucleoside transcriptase inhibitors to HIV-infected patients who previously have taken protease inhibitors. This study also examines how the body handles this combination of anti-HIV drugs.
Interventions
- DRUG Nevirapine
- DRUG Lopinavir/Ritonavir
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004580
The ClinicalTrials.gov registry entry for NCT00004580 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nevirapine is the first listed.
NCT00004580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004580 about?
NCT00004580 is a clinical study titled "A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors". The purpose of this study is to see if it is safe and effective to give ABT-378/ritonavir combination plus nevirapine plus two nucleoside transcriptase inhibitors to HIV-infected patients who previously have taken protease inhibitors. This study also examines how the body handles this combination of...
What is the current status of trial NCT00004580?
This trial is currently completed. It is a Phase 1 study.
What interventions are being tested in trial NCT00004580?
The interventions under investigation include: Nevirapine (DRUG), Lopinavir/Ritonavir (DRUG).
Who is sponsoring clinical trial NCT00004580?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.